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Antigen binding by serum Ig-M (IgM) protects against microbial
infections and helps to prevent autoimmunity, but causes life-
threatening diseases when mistargeted. How antigen-bound IgM
activates complement-immune responses remains unclear. We pre-
sent cryoelectron tomography structures of IgM, C1, and C4b
complexes formed on antigen-bearing lipid membranes by normal
human serum at 4 °C. The IgM-C1-C4b complexes revealed C4b
product release as the temperature-limiting step in complement
activation. Both IgM hexamers and pentamers adopted hexagonal,
dome-shaped structures with Fab pairs, dimerized by hinge do-
mains, bound to surface antigens that support a platform of Fc
regions. C1 binds IgM through widely spread C1q-collagen helices,
with C1r proteases pointing outward and C1s bending downward
and interacting with surface-attached C4b, which further interacts
with the adjacent IgM-Fab2 and globular C1q-recognition unit.
Based on these data, we present mechanistic models for antibody-
mediated, C1q-transmitted activation of C1 and for C4b deposition,
while further conformational rearrangements are required to form
C3 convertases.
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Secreted IgM complexes in human serum occur as (disulfide-linked) pentamers and hexamers of monomeric antibody
complexes (SI Appendix, Fig. S1A). They are the first antibodies
to recognize antigens on newly invading microbes (1–3). Weak,
but multivalent, binding affinities concur with polyreactivity of
naturally occurring IgM antibodies that recognize various danger
and damage signals on microbes and host cells (1). Natural IgM-
induced complement opsonization of apoptotic host cells yields
clearance by phagocytosis, without causing inflammatory re-
sponses (4, 5). Deficiency in either IgM or the early complement
components C1, C4, or C2 causes failure in silent clearance and
is strongly linked to autoimmune diseases, such as systemic lupus
erythematosus (6, 7). However, complement activation by IgM
autoantibodies against, for example, gangliosides on peripheral
nerves causes neuropathies and Guillain-Barré syndrome (8).
Although IgM antibodies and IgM-mediated complement activa-
tion play important roles in immune responses and tissue homeo-
stasis, the underlying molecular processes of IgM immune-complex
formation and complement activation have remained largely un-
clear. Hexameric or pentameric IgM complexes adopt large stellate
structures in solution that undergo a marked conformational change
into a staple-like arrangement upon binding to surface-exposed
antigens (9, 10). While fivefold and sixfold structural models of
soluble IgM pentamers and hexamers have been proposed (11–13),
the overall organization of domains in intact IgM pentamers and
hexamers, and their transitions from solution to complement-
activating surface-bound states, have remained elusive.
C1 consists of a multimeric C1q-recognition molecule and four
associated proteases C1r2s2 (14) (SI Appendix, Fig. S1B). C1q is a
hexamer of the heterotrimeric chains A, B, and C, forming a bundle
of six (heterotrimeric) collagen helices with six (heterotrimeric)
globular C1q (gC1q) recognition units at the C termini and an
N-terminal stalk of 18 peptide chains with disulfide cross-links
between A-B and C-C chains, respectively, within and between
collagen helices (15). C1r and C1s are homologous serine proteases,
each consisting of six domains (SI Appendix, Fig. S1C). The N-
terminal (CUB1-EGF-CUB2) domains of C1r and C1s bind C1q-
lysine residues through Ca2+-binding sites in the CUB1 and CUB2
domains of C1r and CUB1 of C1s (16, 17), yielding a hetero-
tetrameric C1r2s2 CUB1-EGF-CUB2 platform positioned between
the C1q-collagen helices (17–19). Binding of C1q to surface-bound
immune complexes activates proenzymes C1r and C1s that are
associated with C1q. Subsequently, activated C1 proteases cleave
the complement component C4 into C4b (SI Appendix, Fig. S1D),
which propagates the classical pathway of complement (14) (SI
Appendix, Fig. S1E). Previous studies revealed that IgG antibodies
oligomerize on surfaces to activate complement through forming
Fc platforms that present C1q-binding sites separated by 9–18 nm
(20–22). However, disorder in C1-IgG1 complexes limited the
resolution of previous EM studies, hindering complete modeling.
Results
Imaging IgM-C1 Complexes on Liposomes.We generated a synthetic
peptide mimotope of CD52 (23) conjugated to cholesterol and
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formed liposomes with 1-mol% CD52-cholesterol haptens, en-
capsulating self-quenching sulforhodamine B to allow spectro-
scopic measurement of membrane-attack-complex pore formation
through release of the fluorophore (24). In the presence of mono-
clonal rat anti-CD52 IgM (25) and normal human serum (NHS),
rapid lysis of antigenic liposomes was observed (SI Appendix, Fig.
S2A). No lysis was detected over long time periods (up to 1 h) at 4 °C
(26), while complement activity was rapidly reconstituted after rais-
ing the temperature of the sample to 21 °C (SI Appendix, Fig. S2B).
Next, we used phase-plate cryoelectron tomography to image
CD52-mimotope–bearing liposomes in the presence of anti-
CD52 IgM and NHS, as a source of (nonpurified) complement
proteins. Cryotomograms of samples kept for 20 min at 4 °C
before vitrification showed clear C1 binding (SI Appendix, Fig.
S2C), while cryotomograms of samples subsequently warmed to
21 °C for 20 min showed C1 binding, extensive opsonization, and
pore formation (SI Appendix, Fig. S2D). Subvolumes of IgM-C1
complexes were selected from 54 phase-plate tomograms, col-
lected from samples incubated at 4 °C. Averaging and classifi-
cation of 1,522 particles yielded separate classes for pentameric
and hexameric IgM bound to C1 at ∼26-Å resolution (Fig. 1 and
SI Appendix, Fig. S3). Surface-bound IgM pentamers and hex-
amers bind C1 at 4 °C in a far more structurally homogeneous
manner than observed for C1-IgG hexamers (22). Density was
present for IgM, C1q, and the four C1r and C1 proteases and, to
our surprise, for C4b bound to IgM-C1 (Fig. 1).
Surface-Bound IgM Pentamers and Hexamers. Class-averaged den-
sities revealed that IgM pentamers and hexamers, bound to
surface antigens and in complex with C1, adopt isomorphic, C6-
symmetric dome-shape structures of ∼13.5-nm height and ∼28-nm
width (Fig. 2 A–C). The IgM pentamer thus is structurally
equivalent to an IgM hexamer, with its five protomers separated
by ∼60° and one replaced by a J chain (Fig. 2C).
Sixfold averaging of the top platform of the hexameric dome-
shaped structure yielded a map at 20-Å resolution (Fig. 2D and
SI Appendix, Fig. S3). Independent fitting of two monomeric Cμ3
domains and one dimeric Cμ4/4′ unit (12) yielded a ring of Fc
units, similar to that of oligomerized IgG1 molecules (20, 22)
(Fig. 2 D and E). The GlcNAc2Man8-glycosylated C-terminal
μ-chain tail (Cμt) extensions (27) accounted for the central
density of ∼40-nm3 volume (Fig. 2C). The observed arrangement
agrees with cross-linking of Cμ3 Cys414 residues between neigh-
boring Fc units (28) and between Cys575 residues of the Cμt
extensions, needed for IgM oligomerization (29) (SI Appendix,
Fig. S4A).
Below the IgM-Fc platform the density bent down toward the
membrane (Fig. 2B). Density directly below the Fc platform
fitted crystal structures of a Cμ2/2′ dimer (12) at angles of ∼100°
with respect to the Fc platform (Fig. 2 B and C). Below the Cμ2/
2′-hinge domains, the densities extended into pairs of Fab arms
forming an inner and outer ring of surface-bound Fabs. Fitting
Fab structures (30) into the density indicated that all (10 or 12)
antigen-binding regions are bound to surface antigens (Fig. 2B
and SI Appendix, Fig. S4B). The lower resolution of the Fab
densities close to the membrane perhaps indicates increasing
flexibility with increasing distance from the Cμ2 hinge region.
Compared with sixfold symmetric positions, the Fab2 arms ad-
jacent to C4b densities were shifted up to ∼2.5 nm, indicating
steric rearrangements upon C4 binding or C4b production (SI
Appendix, Fig. S4C).
Multivalent surface binding by IgM induces conformational
changes that expose the critical DLPSP (Asp-Leu-Pro-Ser-Pro) res-
idues 432–436 for C1 binding (31) (SI Appendix, Fig. S5). In the
observed IgM-C1 complexes, these residues in the Cμ3 domains were
positioned on the periphery of the Fc platform spaced 8.8–17.5 nm
Fig. 1. IgM-C1-C4b complexes imaged by phase-plate cryoelectron tomog-
raphy. (A) Top and two side views of the hexameric IgM-C1-C4b2 density map.
Shown are assemblies containing C1q (blue), two molecules of C1r (purple),
two molecules of C1s (pink), hexameric IgM (green), and two molecules of C4b
(cyan) formed on liposome bilayers (gray). (Right) Relative heights of compo-
nents are indicated along with a simplified schematic of the complex. (B)
Density map of the pentameric IgM-C1-C4b2 complex indicating twomolecules
of C4b (cyan arrowheads) and two C1s arms (pink arrowheads). Weak density
is observed for the C1q leg above empty space and noisy density of pentameric
IgM (white arrowhead). (C) Density map of the pentameric IgM-C1-C4b1
complex, showing a single molecule of C4b (cyan arrowhead) and the associ-
ated C1s CCP1/2-SP domains (pink arrowhead). On the opposite side disor-
dered noisy density (gray) and increased flexibility of C1s due to the absent
C4b molecule are apparent as missing density (white arrowheads).
Fig. 2. Pentameric and hexameric IgM complexes form dome-shape struc-
tures. (A) Tomographic slices through the Fc platforms of hexameric IgM-C1-
C4b2 (Left), pentameric IgM-C1-C4b2 (Middle), and pentameric IgM-C1-C4b1
(Right) showing 60° spacing of protomers. The site of the missing IgM pro-
tomer in the pentameric Fc platforms is indicated (white arrowheads). (B)
Side view of the hexameric IgM complex fitted into the density, showing
binding of both Fab2 arms (green) to the antigenic surface, dimeric Cμ2/2′-
hinge domains (cyan), and the Fc (Cμ3–4/3′-4′) platform (Cμ3 and Cμ4 do-
mains are colored blue and purple, respectively). DLPSP residues (432–436)
are colored orange (top face) and red (bottom face). (C ) Models of
pentameric IgM (Left) and hexameric IgM from the side (Middle) and top
(Right). The region for the 18 Cμt peptide extensions is indicated by yellow
circles, the positions of the DLPSP residues mediating C1q binding are shown
in orange, and the putative site for the J-chain is shown as a red ellipse in the
pentameric complex. A single protomer in hexameric IgM is colored gray. (D)
Fc platform comprising Cμ3 and Cμ4 domains fitted into the C6-symmetrised
density map. (E) Top view of the hexameric IgM model (colored) overlaying
the hexameric IgG Fc platform (gray). The distance between adjacent DLPSP
motifs (orange) is 8.8 nm (orange hexagon). (Inset) A side view of a Fc region
indicating the 31-Å Cα distance between Pro434-Pro434’ (dashed line) in IgM
(blue) with DLPSP (orange and red, as described above) and hexamerized
IgG1 (gray) aligned to the homologous ALPAP residues (gray spheres).



















































apart (Fig. 2E), similar to the homologous ALPAP (Ala-Leu-Pro-
Ala-Pro) residues of IgG1, which were 8.9–17.9 nm apart in the
IgG1-C1 complexes (22). Furthermore, the IgM-Fc regions displayed
“open” configurations as seen in IgG1-C1 complexes (22), as char-
acterized by the 31-Å distances between Pro434 residues in Cμ3 and
Cμ3′ of one Fc (Fig. 2E), yielding alternating upward and downward-
oriented DLPSP peptides on Fc-Cμ3 and Cμ3′ domains, respectively.
C1q Binding to IgM. The ∼27-Å resolution density map of C1 in
complex with hexameric IgM revealed density for all components
of the C1 (C1qr2s2) complex (Fig. 3A and SI Appendix, Fig. S6 A–
F). The density was consistent with six C1q-collagen helices that
extend down, with a right-handed supercoil, from a tilted stalk to
gC1q modules that are bound to the hexameric IgM-Fc platform
(Fig. 3B), and with four C1r and C1s proteases that create a
platform between the C1q-collagen helices with four protruding
arms, two of which point straight out parallel to the membrane
and two of which bend down toward the densities for C4b (Figs.
1A and 3A). Densities at ∼26-Å resolution of pentameric IgM-
C1 complexes revealed very similar C1 structures, with five C1q
legs bound to the IgM-Fc platform and a sixth leg hovering above
the missing element (Fig. 1 B and C).
C1 caps the top of the dome-shape structures by gC1q binding
to all (five or six) exposed DLPSP sites of the IgM-Fc platforms
(Fig. 3C). Even though the Fc platforms of both pentameric and
hexameric IgM and hexamerized IgG1 (22) have comparable
widths (17.4 and 17.9 nm, respectively), the C1q-collagen helices
are spread markedly wider apart in IgM-C1 complexes than in
IgG1-C1, with their collagen ends separated by 24 nm instead of
19 nm (SI Appendix, Fig. S6 G and H). A kink in the collagen-
gC1q connection allows edge-on positioning of the gC1q modules,
enabling residues ArgB150 and PheB178 of the C1q (22) to interact
with the DLPSP-containing FG loop of Fc Cμ3, and ArgB108 with
the BC loop of Cμ3′ (32) (SI Appendix, Fig. S6I). Overall, the
wider structure of C1q brings the platform of C1r-C1s protease
in C1-IgM ∼1.5 nm closer to the antibody-Fc platform than
in C1-IgG1.
IgM-Mediated C1 Activation. Density of the protease platform and
its four protruding arms accounted for all six (CUB1-EGF-
CUB2-CCP1-CCP2-SP) domains of two C1r and two C1s molecules
(Fig. 3A). The C1r2s2-protease platform between the C1q-collagen
arms is formed by two antiparallel dimers, each consisting of an-
tiparallel arranged N-terminal domains of C1r and C1s, analogous
to previous models (17–19). The density revealed the two outer-
most molecules bending down toward the C4b density (Fig. 3A).
Since it is C1s that binds and cleaves C4, this implies a C1s-C1r-
C1r-C1s stacking of the CUB1-EGF-CUB2 domains, which is
consistent with the heterotetrameric arrangement of C1r and C1s
CUB1-EGF-CUB2 fragments found in the asymmetric unit of a
recent crystal structure (33). Remodeling of C1r2s2 CUB1-EGF-
CUB1 in the density of C1-IgG1 (22) improved the fit and thus
provides additional evidence for the model (SI Appendix, Fig.
S7A). In these models of IgM-C1 and IgG1-C1, each stable C1rs
dimer binds three collagen helices through their binding sites
on C1r CUB1 and CUB2 and C1s CUB1 (Fig. 4A), while the
two C1r molecules in the middle bind the same two central
C1q-collagen helices, resulting in a head-to-tail C1r CUB1-EGF-
CUB2 arrangement and antiparallel binding of the two C1rs
heterodimers.
C1r-C1r interactions are mediated by two central C1q-
collagen helices in IgM-C1 and IgG1-C1 (Figs. 3A and 4A),
whereas in the C1r2s2 CUB1-EGF-CUB2 crystal structure (33)
the domains of the two C1r molecules interact directly with each
other (Fig. 4B). The two observed arrangements differ pre-
dominantly by a single sliding motion of the C1rs heterodimers,
with stable cores consisting of CUB1-EGF-CUB2 of C1r and
CUB1-EGF of C1s. Each C1rs heterodimer is associated with
three collagen helices that are invariant with respect to the
translation and remain accessible, while the “collagen-bridging”
C1r-CUB2 sites are obstructed for collagen binding in the C1r2s2
CUB1-EGF-CUB2 crystal structure (Fig. 4 A and B). Moreover,
projection of collagen helices onto the crystal structure suggests
an apparent hexagonal configuration for C1q binding (Fig. 4B).
In contrast, in IgM-C1 and IgG1-C1 (22) we observed a skewed
configuration of C1q collagens bound to C1r and C1s (Fig. 4A),
while in these complexes gC1q units were bound to sixfold sym-
metric Fc platforms. Considering the stiffness of collagens (34), a
single sliding motion of two halves of the C1 complex may convert
nonskewed and skewed hexagonal arrangements of C1r2s2-bound
collagen and gC1q units, respectively, in unbound C1 to vice versa
arrangements in antibody-bound C1 (Fig. 4C and Movie S1).
C4b Bound to IgM-C1 Complexes. The maps revealed additional
densities adjacent to the IgM-Fab arms that corresponded to
C4b (35) with the thioester-containing domain (TED) positioned
next to the inner Fab and its thioester moiety oriented toward
the membrane, consistent with covalent attachment to the sur-
face (Fig. 5A and SI Appendix, Fig. S1D). Particle classification
resulted in two populations of structures of pentameric IgM-C1,
with either one or two C4b molecules present, and only one for
hexameric IgM-C1 with two C4b molecules bound (Fig. 1). In all
Fig. 3. C1 binding to hexameric IgM platforms. (A) Model of C1qr2s2 in density (truncated below the IgM Fc platform) bound to hexameric IgM showing the
orientations of C1r and C1s. (Below) Central slices through the model. The Inset displays the CUB1 and CUB2 domains of the two antiparallel C1r molecules
binding to C1q-collagen helices. (B) C1q has six collagen legs spiraling down to hexagonally arranged globular head domains. (C) Binding of heterotrimeric
gC1q units to DLPSP residues (orange) of the FG loop of Fc Cμ3 (SI Appendix, Fig. S6).































three cases, the C1q stalk was tilted toward the side of the single-
bound C4b or toward the C4b with the strongest density in classes
where two C4b complexes were present (SI Appendix, Fig. S8).
There was no density for the C1s CCP1-CCP2-SP arm above the
C4b-absent site (Fig. 1C and SI Appendix, Fig. S8), indicating that
the C1s arm by itself is flexible without the C4b-C1s interactions,
consistent with the disorder observed in the C1-IgG1 complex (22).
Modeling C4b (35) into the density maps indicated that C4b
interacts with multiple components of C1 and IgM (Fig. 5 B and
C). Specific electrostatic interactions needed for C1s-C4 binding
(SI Appendix, Fig. S9A) (36) were also shown to be between
CCP1-CCP2 and the C-terminal C345c (CTC) domain of C4 in
the structure of the C1s homolog MASP2 CCP1-CCP2-SP
complexed with C4 (37, 38) but were not present between C1r
and C4b (SI Appendix, Fig. S9B). These are possibly maintained
and supported by additional contacts between C1s SP and
macroglobulin (MG) domain 8 of C4b (Fig. 5C). Furthermore,
gC1q contacts the helices on top of the C4b CTC, C4b-core
domains MG1 and MG5 contact the adjacent outer IgM-Fab
arm, while the newly formed, negatively charged (35), α′-chain
N-terminal region (bound onto MG7) exhibits potential elec-
trostatic interactions with gC1q (Fig. 5C). At the other side, C4b
TED contacts the variable region of the inner Fab arm. Inter-
actions of C4b with both the inner and outer arms of the adjacent
Fab2 are likely responsible for the induced structural changes
that widen the Fab-Fab distance from 6 to 8 nm and distort the
sixfold symmetry of IgM (SI Appendix, Fig. S4C).
Discussion
Activation of the complement cascade at 4 °C leads to the for-
mation of IgM-C1-C4b complexes on the membrane surface, as
observed by cryo-EM tomography of samples containing IgM,
human serum, and antigen-bearing liposomes (Fig. 1 and SI
Appendix, Fig. S2). Density reconstruction up to ∼26–27 Å res-
olution of liposome-associated IgM complexes revealed that IgM
pentamers and hexamers adopt dome-shaped structures on the
membrane (Fig. 2), which are highly reminiscent of images of the
previously described staple conformation (9). The IgM dome-
shaped structures are formed by (five or six) antibody protomers
creating a platform of Fc regions on top, comprising Cμ3-Cμ4/
Cμ3′-Cμ4′ Fc domains, and Cμt extensions filling the central hole.
The Fc platforms are supported by dimeric Cμ2/2′ domains and
Fab2 regions that yield an inner and outer ring of bound Fabs with
their antigen-binding regions oriented toward the membrane,
consistent with binding the short CD52 peptide mimotopes (Fig.
2). The pair-wise surface binding of IgM-Fab2 arms differs from
that of surface-bound structures of IgG1-C1, where only one arm
of each Fab pair binds surface antigens (20, 22) (SI Appendix, Fig.
S4D). Most likely, the dimeric Cμ2/Cμ2′ domains in IgM restrain
the two connected Fab arms to adopt correlated orientations,
whereas independently flexible hinge regions in IgG1 leave the
Fig. 4. Comparing C1r2s2 in the IgM-C1-C4b com-
plex and the isolated crystal structure suggests a
mechanism for C1 activation. (A) Interactions of C1q-
collagen helices with C1r and C1s observed in IgM-
C1; structures of CUB1-EGF-CUB2 domains in C1r and
C1s with positions of C1q indicated by blue circles
with specific binding to collagen-binding sites in-
dicated by connecting black lines. Schematic shows
the C1rs cores with positions of collagen arms. (B)
Crystal structure (Protein Data Bank code 6F1C) (33)
and schematic representations of C1rs heterodimers
with projected collagen locations added (blue cir-
cles), as deduced from C1-IgM; the two obscured
collagen positions are indicated by red circles and
lines. (C) Schematic representation of C1 conforma-
tional rearrangement upon binding to antibody-Fc
platforms; with C1q (blue), C1rs heterodimers (pur-
ple), and antibodies (green). Empty sites for anti-
body binding are indicated in gray; C1q positions at
the height of the proteases by small blue circles; gC1q headpieces by large blue circles, connecting C1q collagen helices by blue bars; and upright and tilted
C1q stalks as a blue circle or ovoid. Dotted lines highlight the hexagonal arrangements. The sliding motion of two halves of the complex is indicated by the
colored arrow. See also Movie S1.
Fig. 5. C4b binding to IgM-C1 complexes. (A) The
full model in density of the hexameric IgM-C1-C4b2
complex, colored as in Fig. 1. (Inset) The C4b density
fit. (B) Protein interaction map showing the domains
mediating binding between the protein complexes.
(C) Interactions of C4b (surface model) with IgM,
C1q, and C1s (ribbon models) are indicated by dashed
boxes. C4b colored as in SI Appendix, Fig. S1. (D)
Hypothetical IgM-C1-C4 model. The TED domain is
structurally unhindered and free to rearrange upon
cleavage to C4b. (E) Hypothetical IgM-C1-C4bC2 model
showing steric clashes with both the Fc and Fab re-
gions of IgM.



















































orientations of the two Fab arms largely unrestrained, yielding the
observed difference in surface binding. Analogous to oligomeri-
zation of surface-bound IgG, gradual surface binding of adjacent
Fab2 arms bends the hinges preceding the Fc segments orienting
connected Cμ2/Cμ2′-Fab2 toward the membrane. This stellate to
dome-shaped conformational change upon membrane binding
exposes the Fc-Cμ3 FG loops that contain the DLPSP residues
critical for C1 binding (31) on the periphery of the IgM-Fc plat-
form (SI Appendix, Fig. S5).
Both IgM hexamers and pentamers bind and activate C1
through adopting (respectively, complete and incomplete) hex-
agonal arrangements, irrespective of the substitution of one an-
tibody protomer by a J chain (Fig. 1). In solution, however, IgM
pentamers do not adopt hexagonal symmetry (39), implying that
C1 binding directs IgM pentamers to adopt hexagonal symmetry.
The C1-binding and activating Fc platforms generated by
surface-bound IgM pentamers and hexamers are remarkably
similar to those generated by surface-bound and oligomerized
IgG1 molecules. Both expose C1q-binding sites on the periphery
of the hexagonal platforms at 8.8- to 17.5-nm distances in IgM
(Fig. 2E) and 8.9–17.9 nm in hexamerized IgG1 (22). However,
C1 binds IgM through spreading its C1q helices far more widely
than when binding IgG1 complexes, with angles between the
adjacent collagen helices of ∼98° instead of ∼70°, respectively (SI
Appendix, Fig. S6G). As a consequence, the IgM-C1q bound C1r2s2
protease platform is lowered by ∼1.5 nm with respect to the
membrane surface, which compensates partially for the increase in
height of ∼2.5 nm due to the presence of Cμ2/Cμ2′ domains in IgM
(SI Appendix, Fig. S6G andH). Overall, pentameric and hexameric
IgM form highly similar complement-activating complexes on
membranes that appear structurally more homogeneous and or-
dered than surface-bound and hexamerized IgG1-C1 complexes.
The densities for C1r and C1s proteases in the IgM-C1-C4b
complexes reveal that the heterotetramer of C1r and C1s binds
C1q in an antiparallel stacked arrangement with C1r molecules
on the inside and C1s on the outside, thus reversing previous
C1r-C1s-C1s-C1r stacking models into C1s-C1r-C1r-C1s (17, 18).
In IgM-C1-C4b, densities of the two “outside” arms are oriented
down to interact with C4b (Fig. 3A). Since C1s, and not C1r,
cleaves C4 to produce C4b, we conclude that C1r proteases are
positioned on the inside and C1s on the outside, yielding an
antiparallel stacking of C1s-C1r-C1r-C1s. This same stacking
arrangement was also observed in a recent crystal structure (33)
and is confirmed by an improved fit after remodeling of C1-IgG1
density from single-particle data (SI Appendix, Fig. S7) (22). In
the new C1s-C1r-C1r-C1s model, the collagen-binding sites in
the CUB1 and CUB2 domains of the two central antiparallel C1r
molecules bind the two C1q-collagen helices in the middle (Figs.
3A and 4A). The collagen-binding sites in the CUB1 domains of
the two C1s molecules each bind C1q collagen helices positioned
on the outside. Variable orientations of C1s CUB2 (19, 22, 33)
(SI Appendix, Fig. S7B) reflect the absence of specific collagen-
binding interactions with the remaining C1q-collagen helix on
either side (17). The absence of collagen binding to C1s CUB2
likely provides the molecular complex an increased flexibility for
its C1s CUB2-CCP1-CCP2-SP arms, accounting for diverse ar-
rangements needed in order for C1s to be cleaved by C1r and to
reach and, subsequently, cleave its substrates C4 and C4bC2 (SI
Appendix, Figs. S9 and S10).
Comparing our model of IgM-C1 with the crystal structure of
C1r2s2 CUB1-EGF-CUB2 (33) led us to hypothesize that the
configuration observed in the crystal structure may reflect the
C1r2s2-C1q arrangement as occurs in (unbound) C1 in solution,
yielding a mechanism for surface-triggered activation of C1 upon
binding to surfaced-bound IgM and oligomerized IgG complexes
(Fig. 4). Projection of the C1q-collagen helices at accessible sites
in the crystal-structure configuration suggests a near-hexagonal
arrangement of C1q collagen bound to the C1rs protease dimers
(Fig. 4B). In contrast, a skewed arrangement of C1q helices is
observed when bound to C1r and C1s in the IgM-C1 and IgG1-
C1 complexes, while the gC1q units in these complexes are re-
strained to a hexagonal configuration due to binding the hex-
agonal Fc platforms (Figs. 3C and 4A). We hypothesize that C1
functions as two halves, each formed by a stable C1rs hetero-
dimer that associates with three adjacent C1q-collagen helices
(with the outer two C1q-collagen helices bound to the CUB1
domains of C1r and C1s, while the third collagen helix in the
middle is not bound). Binding to hexagonal Fc platforms will
induce the gC1q units of the two halves to adopt hexagonal
symmetry (Movie S1). Transmission of this gC1q rearrangement
through the short, and thereby relatively stiff (34), C1q-collagen
helices skews the arrangement of the collagens at the height of
the proteases, which consequently induces a shift of C1rs dimers
and tilts the C1q stalk along the sliding direction (Fig. 4C and
Movie S1). We previously considered compaction of C1q-
collagen helices as a trigger for activation (22). The wide spread-
ing of C1q-collagen helices in IgM-C1 excludes such a simple
model (SI Appendix, Fig. S6 G and H). In agreement with C1q
compaction, however, our current hypothesis specifies a single
sliding motion that transforms a skewed arrangement of gC1q into
a hexagonal one upon gC1q binding to Fc platforms, which com-
pacts C1q in one direction and induces rearrangement of the
C1r2s2 protease platform.
At 4 °C, C4 cleavage by IgM-C1 on liposomes leads to for-
mation of IgM-C1-C4b complexes that block C4 turnover and
C4b deposition. Superposing C4 (37) onto C4b in the IgM-C1-
C4b structures (Fig. 5D) suggests that binding of C4 initially
involves interactions through C4-substrate binding to C1s CCP1-
CCP2-SP (37) supported by interactions that latch C4 CTC onto
gC1q (Fig. 5 B and C). Cleavage of C4 into C4b induces large
structural rearrangements that expose the thioester moiety in
C4b TED for covalent attachment to the surface (Fig. 5A). In
addition, a conformational switch of the C4b CTC-anchor region
(residues 1,579–1,593) from α-helix to β-hairpin [as previously
observed in structures of C3 and C4 (35, 37, 40)] allows the
MG1–6 core of C4b to align with the outer Fab arm. The final
structure of IgM-C1-C4b is in agreement with covalent attach-
ment of C4b to the membrane and IgM-C1 binding of C4b
through C4b interactions with gC1q, CCP2-SP of C1s, and both
Fab arms (Fig. 5 B and C). Displacement of the Fab arms by C4b
(SI Appendix, Fig. S4C), yielding the final IgM-C1-C4b struc-
tures, implies mobility or flexibility of the epitopes, which is fa-
cilitated by membrane fluidity, but may be restricted in the case
of antigens on solid surfaces.
Cleavage of C4 by IgM-C1 leads to C4b opsonization and,
next, formation of C3 convertases leading to opsonization by
C3b. The state captured here, IgM-C1-C4b at 4 °C, indicates C4b
product release as a temperature-limited step in the complement
cascade. Moreover, docking of proenzyme C2 onto C4b in IgM-
C1-C4b [based on the homologous structure of C3bB in complex
with its protease factor D (41) (Fig. 5E)] results in steric clashes,
indicating that formation of the C4b-C2 proconvertase complex
also requires conformational changes that apparently do not
occur at 4 °C. The observation of stable IgM-C1-C4b complexes
at 4 °C suggests the presence of (weak) interactions that facili-
tate, on the one hand, C4b release and C4 turnover yielding C4b
deposition, and, on the other hand, the retention of C4b close to
C1 for C2 binding and cleavage of C4bC2 by the resident C1s.
Previous cryo-EM tomograms of IgG-C1 complexes, formed on
liposomes at ambient temperature when using C2-depleted sera,
showed potential individual occurrences of related IgG-C1-C4b
complexes (42) (SI Appendix, Fig. S9C). Notably, the height
difference between surface-bound IgM and hexamerized IgG1 is
in part compensated by the height difference due to the two dif-
ferent modes of C1 binding to IgM and IgG1 hexamers (SI Appen-
dix, Fig. S6H). Evidently, higher temperatures allow conformational































changes to occur and expose C4b for C2 binding, thus generating
C4bC2 complexes. Based on the homologous C3bB in complex
with its protease factor D (41), a reorientation of C1s SP-catalytic
domain would be needed after C4 cleavage to subsequently cleave
C4bC2 and generate a C4b2a complex or C3 convertase (SI Ap-
pendix, Fig. S9D).
In conclusion, we used a mimic of the short CD52 antigen and
a cognate CDC-inducing monoclonal IgM antibody to obtain
stable and homogeneous complexes of IgM-C1-C4b formed at
4 °C on liposomal membranes. The resulting structures of IgM
pentamers and hexamers in complex with C1 and C4b reflect
geometries of antibodies bound close to lipid bilayers for bind-
ing, activation, and activity of C1, producing C4b that is de-
posited directly onto the targeted surface. However, C1 reacts
in vivo upon binding to a range of variable patterns presented on
diverse surfaces, either by direct C1 binding or via antibodies or
other mediators of inflammation (see, e.g., ref. 43). These insights
enable design of further experiments to determine effects of im-
portant parameters, such as epitope location and orientation,
antigen density and diffusion of antigens, and type of mediator
(44–46). Moreover, diverse conditions encountered in vivo may
influence the packing and stability of C1-C4b complexes, which in
turn may affect the relative rates of C4b deposition and C3
convertase (C4b2a) formation. How and whether these effects
contribute to distinguish self from nonself, and how complement
processes host cells versus microbes, remains to be established.
Materials and Methods
Synthesis of CD52 and Complement Activation Fluorescence Assay. A CD52
mimotope with the amino acid sequence TSSPSAD was synthesized by solid-
phase peptide synthesis and used to form antigenic liposomes as described in
SI Appendix. Complement activity was assessed as described in SI Appendix.
Cryoelectron Tomography and Subtomogram Averaging. Samples were pre-
pared for cryo-EM and imaged as described in SI Appendix. Tomograms were
reconstructed (SI Appendix) before particles of IgM-C1 complexes were
picked, aligned, and classified using multireference alignment as described
in SI Appendix.
Model Building. Models were constructed as described in SI Appendix. The
structures used for the final models are summarized in SI Appendix, Table S1.
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